Ligand validation:3HY5

RET: RETINAL

RET is a Ligand Of Interest in 3HY5 designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
3HY5_RET_A_400	7%	0%	0.446	0.907	6.23	3.52	12	14	4	0	100%	1
4CJ6_RET_A_1307	63%	40%	0.126	0.922	0.76	1.55	-	4	0	0	100%	1
3HX3_RET_A_400	56%	6%	0.116	0.885	0.83	4.03	-	16	10	0	100%	1
4CIZ_RET_A_1307	7%	62%	0.417	0.944	0.59	0.86	-	1	0	0	67%	1
4OV0_RET_A_301	100%	8%	0.027	0.992	0.76	3.77	-	15	8	0	100%	1
9F9J_RET_A_317	100%	71%	0.026	0.991	0.7	0.44	1	-	5	0	100%	1
3UTY_RET_A_301	100%	5%	0.028	0.992	2.48	2.7	6	12	2	0	100%	1
7XJC_RET_A_301	100%	10%	0.028	0.992	1.93	2.43	2	14	2	0	100%	0.5
7XJD_RET_A_301	100%	10%	0.029	0.991	1.93	2.42	2	14	2	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.